Intron A

Active Ingredient(s): Interferon Alfa-2b
FDA Approved: * October 4, 1983
Pharm Company: * SCHERING
Category: Hepatitis

Interferon alfa-2b is an antiviral or antineoplastic drug. It is a recombinant form of the protein Interferon alpha-2 that was originally sequenced and produced recombinantly in E. coli[1] in the laboratory of Charles Weissmann at the University of Zurich, in 1980.[2][3] It was developed at Biogen, and ultimately marketed by Schering-Plough under the trade name Intron-A. It was also produced in 1986 in recombinant human form, in the Center for G... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Intron a Kit

NDC: 0085-0539

Labeler:

Merck Sharp & Dohme Corp.

Intron a Kit

NDC: 0085-0571

Labeler:

Merck Sharp & Dohme Corp.

Intron a Kit

NDC: 0085-1110

Labeler:

Merck Sharp & Dohme Corp.

Intron a 19.2 ug/.5ml Intralesional; Intramuscular; Subcutaneous Injection, Solution

NDC: 0085-1133

Labeler:

Merck Sharp & Dohme Corp.

Intron a 11.6 ug/.5ml Intramuscular; Subcutaneous Injection, Solution

NDC: 0085-1168

Labeler:

Merck Sharp & Dohme Corp.

Intron a 19.2 ug/.2ml Subcutaneous Injection, Solution

NDC: 0085-1235

Labeler:

Merck Sharp & Dohme Corp.

Intron a 11.6 ug/.2ml Subcutaneous Injection, Solution

NDC: 0085-1242

Labeler:

Merck Sharp & Dohme Corp.

Intron a 38.4 ug/.2ml Subcutaneous Injection, Solution

NDC: 0085-1254

Labeler:

Merck Sharp & Dohme Corp.

Intron a Kit

NDC: 0085-4350

Labeler:

Merck Sharp & Dohme Corp.

Intron a Kit

NDC: 0085-4351

Labeler:

Merck Sharp & Dohme Corp.

More Results

Dosage List

Popular Topics